USANA Health Sciences, Inc. Forecasted to Earn Q3 2024 Earnings of $0.46 Per Share (NYSE:USNA)

USANA Health Sciences, Inc. (NYSE:USNA) – Investment analysts at DA Davidson issued their Q3 2024 earnings per share (EPS) estimates for USANA Health Sciences in a report issued on Thursday, July 25th. DA Davidson analyst L. Weiser forecasts that the company will post earnings per share of $0.46 for the quarter. DA Davidson has a “Neutral” rating and a $38.00 price target on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.48 per share.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.11). The firm had revenue of $212.87 million for the quarter, compared to analyst estimates of $218.64 million. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. During the same period in the previous year, the business posted $0.89 EPS.

Separately, StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Wednesday.

USANA Health Sciences Price Performance

USNA opened at $41.84 on Friday. The company has a market capitalization of $797.05 million, a P/E ratio of 13.03, a P/E/G ratio of 1.50 and a beta of 0.90. The firm’s fifty day moving average price is $46.27 and its two-hundred day moving average price is $47.07. USANA Health Sciences has a fifty-two week low of $40.51 and a fifty-two week high of $69.60.

Insider Transactions at USANA Health Sciences

In related news, CFO G Doug Iiekking sold 5,198 shares of the business’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total value of $232,662.48. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, insider Paul A. Jones sold 2,714 shares of the stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $48.66, for a total transaction of $132,063.24. Following the completion of the sale, the insider now owns 6,266 shares in the company, valued at approximately $304,903.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO G Doug Iiekking sold 5,198 shares of the business’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total transaction of $232,662.48. The disclosure for this sale can be found here. In the last ninety days, insiders sold 31,591 shares of company stock valued at $1,458,098. Corporate insiders own 0.33% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. CWM LLC grew its position in USANA Health Sciences by 21.8% during the 1st quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after acquiring an additional 276 shares during the last quarter. New York State Common Retirement Fund increased its stake in shares of USANA Health Sciences by 1.2% in the fourth quarter. New York State Common Retirement Fund now owns 24,500 shares of the company’s stock valued at $1,313,000 after buying an additional 279 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of USANA Health Sciences by 9.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock valued at $284,000 after buying an additional 494 shares during the last quarter. Strs Ohio lifted its position in USANA Health Sciences by 9.2% during the 4th quarter. Strs Ohio now owns 11,900 shares of the company’s stock worth $637,000 after buying an additional 1,000 shares in the last quarter. Finally, Quest Partners LLC acquired a new position in USANA Health Sciences during the 4th quarter worth about $66,000. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.